Insider · CIK 0001511034

Mahatme Sandesh

Reports to the SEC for 7 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001511034

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-05	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2025-12-05	VORVor Biopharma Inc.D Disposition to Issuer	CFO	DDisposition to Issuer	−694K sh	—	—	0
2025-12-05	VORVor Biopharma Inc. · Employee Stock Option (right to buy)A Award	CFO	AAward	+1.39M sh	—	—	1,388,274
2025-07-09	VORVor Biopharma Inc.A Award	CFO	AAward	+13.9M sh	—	—	13,882,750
2025-06-05	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2024-05-30	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2022-06-07	SYRESpyre Therapeutics, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+43K sh	—	—	43,000
2021-06-08	SYRESpyre Therapeutics, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2020-07-08	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	+218 sh	$13.71	+$2,988.78	19,057
2020-07-08	SRPTSarepta Therapeutics, Inc. · Stock option (right to buy)M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	−218 sh	$13.71	−$2,988.78	0
2020-07-08	SRPTSarepta Therapeutics, Inc. · Stock option (right to buy)M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	−2,385 sh	$13.71	−$32.7K	0
2020-07-08	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	+1,203 sh	$32.63	+$39.3K	20,260
2020-07-08	SRPTSarepta Therapeutics, Inc. · Stock option (right to buy)M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	−1,203 sh	$32.63	−$39.3K	0
2020-07-08	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	+2,385 sh	$13.71	+$32.7K	18,839
2020-06-10	Flexion Therapeutics IncA Award	Director	AAward	+4,500 sh	—	—	4,500
2020-06-10	Flexion Therapeutics IncStock option (right to buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2020-06-08	SYRESpyre Therapeutics, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+28.1K sh	—	—	28,100
2020-05-11	SRPTSarepta Therapeutics, Inc.G Gift	EVP, CFO & CBO	GGift	−20.4K sh	—	—	16,454
2020-02-28	SRPTSarepta Therapeutics, Inc. · Stock option (right to buy)A Award	EVP, CFO & CBO	AAward	+37.5K sh	—	—	37,500
2020-02-28	SRPTSarepta Therapeutics, Inc.A Award	EVP, CFO & CBO	AAward	+6,700 sh	—	—	36,879
2019-12-13	SRPTSarepta Therapeutics, Inc. · Stock option (right to buy)M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	−14.7K sh	—	—	39,277
2019-12-13	SRPTSarepta Therapeutics, Inc. · Stock option (right to buy)M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	−4,319 sh	—	—	3,085
2019-12-13	SRPTSarepta Therapeutics, Inc. · Stock option (right to buy)M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	−69.5K sh	—	—	0
2019-12-13	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	+69.5K sh	$29.03	+$2.02M	118,581
2019-12-13	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	+4,138 sh	$13.71	+$56.7K	38,636
2019-12-13	SRPTSarepta Therapeutics, Inc.S Sale	EVP, CFO & CBO	SSale	−125K sh	$125.50	−$15.7M	30,179
2019-12-13	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	+14.7K sh	$34.92	+$514K	155,179
2019-12-13	SRPTSarepta Therapeutics, Inc. · Stock option (right to buy)M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	−4,138 sh	—	—	2,633
2019-12-13	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	+21.9K sh	$32.63	+$714K	140,456
2019-12-13	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	+10.5K sh	$23.85	+$250K	49,102
2019-12-13	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	+4,319 sh	$13.71	+$59.2K	34,498
2019-12-13	SRPTSarepta Therapeutics, Inc. · Stock option (right to buy)M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	−21.9K sh	—	—	10,874
2019-12-13	SRPTSarepta Therapeutics, Inc. · Stock option (right to buy)M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	−10.5K sh	—	—	0
2019-08-22	SRPTSarepta Therapeutics, Inc.G Gift	EVP, CFO & CBO	GGift	−42.5K sh	—	—	30,179
2019-08-21	SRPTSarepta Therapeutics, Inc. · Stock Appreciation RightM Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	−100K sh	—	—	0
2019-08-21	SRPTSarepta Therapeutics, Inc.F Tax Payment	EVP, CFO & CBO	FTax Payment	−57.5K sh	$101.50	−$5.83M	72,714
2019-08-21	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	+100K sh	$23.85	+$2.39M	130,179
2019-08-15	SRPTSarepta Therapeutics, Inc. · Stock option (right to buy)M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	−260 sh	—	—	218
2019-08-15	SRPTSarepta Therapeutics, Inc. · Stock option (right to buy)M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	−985 sh	—	—	2,385
2019-08-15	SRPTSarepta Therapeutics, Inc. · Stock option (right to buy)M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	−2,625 sh	—	—	0
2019-08-15	SRPTSarepta Therapeutics, Inc. · Stock option (right to buy)M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	−3,021 sh	—	—	0
2019-08-15	SRPTSarepta Therapeutics, Inc. · Stock option (right to buy)M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	−2,863 sh	—	—	0
2019-08-15	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	+260 sh	$13.71	+$3,564.6	30,179
2019-08-15	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	+985 sh	$13.71	+$13.5K	29,919
2019-08-15	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	+2,625 sh	$13.90	+$36.5K	28,934
2019-08-15	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	+3,021 sh	$29.03	+$87.7K	26,309
2019-08-15	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	EVP, CFO & CBO	MExercise/Conversion	+2,863 sh	$34.92	+$100K	23,288
2019-06-19	Flexion Therapeutics IncStock option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2019-06-07	SYRESpyre Therapeutics, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+12.4K sh	—	—	12,400
2019-03-28	SRPTSarepta Therapeutics, Inc.F Tax Payment	EVP, CFO & CBO	FTax Payment	−2,953 sh	$118.68	−$350K	20,425

Recent filings

Accepted (ET)
Jun 94
Mahatme Sandesh0001193125-26-264286
SEC(opens sec.gov)
Dec 94
Mahatme Sandesh0001511034-25-000006
SEC(opens sec.gov)
Jul 104
Mahatme Sandesh0001415889-25-019640
SEC(opens sec.gov)
Jun 64
Mahatme Sandesh0000950170-25-083269
SEC(opens sec.gov)
May 314
Mahatme Sandesh0000950170-24-067329
SEC(opens sec.gov)
Jun 94
Mahatme Sandesh0001209191-22-035687
SEC(opens sec.gov)
Jun 94
Mahatme Sandesh0001209191-21-039231
SEC(opens sec.gov)
Jul 94
Mahatme Sandesh0001209191-20-042060
SEC(opens sec.gov)
Jun 124
Mahatme Sandesh0001209191-20-036257
SEC(opens sec.gov)
Jun 104
Mahatme Sandesh0001209191-20-035519
SEC(opens sec.gov)
Feb 284
Mahatme Sandesh0001209191-20-014223
SEC(opens sec.gov)

Companies

Address

C/O CRISPR THERAPEUTICS 105 WEST FIRST STREET

BOSTON, MA, 02127